Predictive Oncology Inc. announced plans to introduce its ChemoFx® drug response assay in Europe, which is aimed at enhancing treatment selection for gynecologic cancers, particularly ovarian cancer.
Researchers from Imperial College London are studying the bacteria found in the gut and saliva of pancreatic cancer patients, ...
One of the most elusive challenges oncologists encounter is why some patients respond to a particular therapy while others do not. Thus, optimizing a personalized treatment regimen that gives a ...
Stanford Medicine has developed a vision-language artificial intelligence (AI) model that can predict cancer outcomes, such as forecasting melanoma relapses and patient responses to immunotherapy.
Please provide your email address to receive an email when new articles are posted on . An AI tool outperformed current FDA-approved biomarkers for predicting survival after immune checkpoint ...
Hosted on MSN
Genetic test predicts response to weight-loss drugs
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Subscribe to our newsletter for the latest sci-tech news ...
At the San Antonio Breast Cancer Symposium, investigators reported findings from a retrospective study exploring whether routine blood-based immune markers could help predict response to neoadjuvant ...
Changes in ferritin, lactate dehydrogenase (LDH), erythrocyte sedimentation rate (ESR), albumin, total white cell count (TWC), absolute lymphocyte count (ALC), and absolute eosinophil count were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback